Circulating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathy

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Lee, Su Mi ^a,b   Yang, SeungHee ^a,c   Cha, Ran Hui ^d   Kim, Myounghee ^e   An, Jung Nam ^a,f   Paik, Jin Ho ^g   Kim, Dong Ki ^a,c   Kang, Shin Wook ^h   Lim, Chun Soo ^f   Kim, Yon Su ^a,c   Lee, Jung Pyo ^f  

^a Seoul National University Hospital   (South Korea)

^b Dong A University   (South Korea)

^c Seoul National University   (South Korea)

^d National Medical Center   (South Korea)

^e Eulji University   (South Korea)

^f Seoul National University Boramae Hospital   (South Korea)

^g Seoul National University Bundang Hospital   (South Korea)

^h Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TUMOR NECROSIS FACTOR RECEPTOR; BIOLOGICAL MARKER; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DRUG RESPONSE; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MIDDLE AGED; PREDICTION; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; AGED; BLOOD; GLOMERULONEPHRITIS, MEMBRANOUS; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY;

ADULT; AGED; BIOMARKERS; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

EID: 84905500826     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104354     Document Type: Article

References (44)

1. Rivera F, Lopez-Gomez JM, Perez-Garcia R, Spanish Registry of G (2004) Clinicopathologic correlations of renal pathology in Spain. Kidney Int 66: 898-904. (Pubitemid 39120989)
2. Yokoyama H, Taguchi T, Sugiyama H, Sato H, Committee for the Standardization of Renal Pathological D, et al. (2012) Membranous nephropathy in Japan: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 16: 557-563.
3. Cattran DC (2001) Idiopathic membranous glomerulonephritis. Kidney Int 59: 1983-1994.
4. Cattran D (2005) Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol 16: 1188-1194.
5. Honkanen E, Tornroth T, Gronhagen-Riska C (1992) Natural history, clinical course and morphological evolution of membranous nephropathy. Nephrol Dial Transplant 7 Suppl 1: 35-41. (Pubitemid 23016765)
6. Magil AB (1995) Tubulointerstitial lesions in human membranous glomerulonephritis: relationship to proteinuria. Am J Kidney Dis 25: 375-379.
7. Reichert LJ, Koene RA, Wetzels JF (1998) Prognostic factors in idiopathic membranous nephropathy. Am J Kidney Dis 31: 1-11. (Pubitemid 28116676)
8. Pei Y, Cattran D, Greenwood C (1992) Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 42: 960-966.
9. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, et al. (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21.
10. Shankar A, Sun L, Klein BE, Lee KE, Muntner P, et al. (2011) Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int 80: 1231-1238.
11. Harris RC, Neilson EG (2006) Toward a unified theory of renal progression. Annu Rev Med 57: 365-380. (Pubitemid 43261996)
12. Sean Eardley K, Cockwell P (2005) Macrophages and progressive tubulointerstitial disease. Kidney Int 68: 437-455. (Pubitemid 43323099)
13. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G, et al. (2005) Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68: 237-245. (Pubitemid 43181381)
14. Hasegawa G, Nakano K, Sawada M, Uno K, Shibayama Y, et al. (1991) Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int 40: 1007-1012.
15. Hehlgans T, Pfeffer K (2005) The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115: 1-20. (Pubitemid 40598088)
16. Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, et al. (2008) Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol 294: F945-955.
17. Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, et al. (2012) Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol 23: 516-524.
18. Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, et al. (2012) Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 23: 507-515.
19. Ernandez T, Mayadas TN (2009) Immunoregulatory role of TNFalpha in inflammatory kidney diseases. Kidney Int 76: 262-276.
20. Baud L, Ardaillou R (1995) Tumor necrosis factor in renal injury. Miner Electrolyte Metab 21: 336-341.
21. Timoshanko JR, Sedgwick JD, Holdsworth SR, Tipping PG (2003) Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. J Am Soc Nephrol 14: 1785-1793. (Pubitemid 36750474)
22. Lorenzen I, Trad A, Grotzinger J (2011) Multimerisation of A disintegrin and metalloprotease protein-17 (ADAM17) is mediated by its EGF-like domain. Biochem Biophys Res Commun 415: 330-336.
23. Takahashi K, Honeyman MC, Harrison LC (1998) Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. J Immunol 161: 2629-2635. (Pubitemid 28397083)
24. Lan HY (1998) Therapeutic effects of cytokine blockade in glomerulonephritis. Nephrol Dial Transplant 13: 7-9.
25. Al-Lamki RS, Wang J, Skepper JN, Thiru S, Pober JS, et al. (2001) Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Invest 81: 1503-1515. (Pubitemid 33064276)
26. Hasegawa M, Nishii C, Ohashi A, Tomita M, Nakai S, et al. (2009) Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Nephron Clin Pract 113: c222-233.
27. Zhu L, Yang X, Ji Y, Chen W, Guan W, et al. (2009) Up-regulated renal expression of TNF-alpha signalling adapter proteins in lupus glomerulonephritis. Lupus 18: 116-127.
28. Idasiak-Piechocka I, Oko A, Pawliczak E, Kaczmarek E, Czekalski S (2010) Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis. Nephrol Dial Transplant 25: 3948-3956.
29. Eddy AA (2004) Proteinuria and interstitial injury. Nephrol Dial Transplant 19: 277-281.
30. Navarro JF, Mora-Fernandez C (2006) The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev 17: 441-450. (Pubitemid 44803222)
31. Remuzzi G, Bertani T (1998) Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456. (Pubitemid 28516069)
32. Bertani T, Abbate M, Zoja C, Corna D, Perico N, et al. (1989) Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol 134: 419-430. (Pubitemid 19063898)
33. Fattori E, Della Rocca C, Costa P, Giorgio M, Dente B, et al. (1994) Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood 83: 2570-2579. (Pubitemid 24135849)
34. D'Amico G, Ferrario F, Rastaldi MP (1995) Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis 26: 124-132.
35. Nangaku M (2006) Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol 17: 17-25.
36. Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS (2013) Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS One 8: e62151.
37. Wu T, Xie C, Bhaskarabhatla M, Yan M, Leone A, et al. (2007) Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum 56: 949-959. (Pubitemid 46399442)
38. Hofstra JM, Debiec H, Short CD, Pelle T, Kleta R, et al. (2012) Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 23: 1735-1743.
39. Waldman M, Austin HA 3rd (2009) Controversies in the treatment of idiopathic membranous nephropathy. Nat Rev Nephrol 5: 469-479.
40. Lee CS, Cha RH, Lim YH, Kim H, Song KH, et al. (2010) Ethnic coefficients for glomerular filtration rate estimation by the Modification of Diet in Renal Disease study equations in the Korean population. J Korean Med Sci 25: 1616-1625.
41. Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, et al. (2007) A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol 18: 1899-1904. (Pubitemid 46870326)
42. Sprangers B, Bomback AS, Cohen SD, Radhakrishnan J, Valeri A, et al. (2012) Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center. Am J Nephrol 36: 78-89.
43. Ehrenreich T, Porush JG, Churg J, Garfinkel L, Glabman S, et al. (1976) Treatment of idiopathic membranous nephropathy. N Engl J Med 295: 741-746.
44. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)